BHARAT BIOTECH FOUNDER DR KRISHNA ELLA AWARDED INSA FELLOWSHIP FOR 2025
NEWS Desk Global
The Indian National Science Academy (INSA) has conferred its prestigious India fellowship for 2025 upon Dr Krishna Ella, co-founder and executive chairman of Bharat Biotech, which developed India’s first indigenously developed Covid-19 Covaxin.
The fellowship recognises Dr Ella for his outstanding contributions to the development of new vaccine technologies as well as improvements in existing ones as well as new knowledge and discoveries in the field of biotechnology. Dr Ella’s fellowship term commenced on January 1, 2025.
Kommentare